Carter-Wallace rejects $835 mil. buy-out offer; Trojan raiders?.
This article was originally published in The Tan Sheet
Executive Summary
TROJAN WARS?: CARTER-WALLACE REJECTS $18/SHARE BID BY MARVIN DAVIS on Nov. 1. The Princeton, N.J.-based consumer products and pharmaceuticals company reported Oct. 30 that it received a letter from Davis stating that his Los Angeles-based investment firm Davis Companies is "prepared to negotiate an agreement with [Carter-Wallace] for the acquisition of all of the company's outstanding stock at a price of $18 per share."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: